Epstein Barr virus‐directed T‐cell therapy for refractory EBV‐PTLD in a toddler post Orthotopic heart transplantation
Pediatric Transplantation · 2024
DOI: 10.1111/petr.14707 ↗Kurz gefasst
Fallbericht in der Zeitschrift Pediatric Transplantation, 2024. Verfasst von Emily Work und 13 weiteren Autor:innen. Beteiligte Einrichtung: University of Florida, Gainesville, Florida, USA. Hauptthemen laut MEDLINE: Epstein-Barr Virus Infections, Heart Transplantation, Lymphoproliferative Disorders, Hematopoietic Stem Cell Transplantation. Die Arbeit nennt 9 Literaturangaben.
Abstract (Originalsprache)
Epstein–Barr Virus (EBV) is a ubiquitous herpes type virus that is associated with post‐transplant lymphoproliferative disorder (PTLD). Usual management includes reduction or cessation of immunosuppression and in some cases chemotherapy including rituximab. However, limited therapies are available if PTLD is refractory to rituximab. Several clinical trials have investigated the use of EBV‐directed T cells in rituximab‐refractory patients; however, data regarding response is scarce and inconclusive. Herein, we describe a patient with EBV‐PTLD refractory to rituximab after orthotopic heart transplantation (OHT) requiring EBV‐directed T‐cell therapy. This article aims to highlight the unique and aggressive clinical presentation and progression of PTLD with utilization of EBV‐directed T‐cell therapy for management and associated pitfalls.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- University of Florida, Gainesville, Florida, USA.
- Congenital Heart Center, University of Florida, Gainesville, Florida, USA.
- Division of Hematology and Oncology, University of Florida, Gainesville, Florida, USA.
- Department of Radiology, University of Florida, Gainesville, Florida, USA.
- Department of Pathology, University of Florida, Gainesville, Florida, USA.
ORCID-Profile: Dipankar Gupta, Robert Seifert, Giles Peek, Sukumar Suguna Narasimhulu
Zitieren
APA
Work, E., Gupta, D., Slayton, W. B., Rees, J., Coppola, J. A., Seifert, R., Bleiweis, M. S., Jacobs, J. P., Peek, G., Philip, J., Brock, A., Rivera, J. H., Sullivan, K., & Narasimhulu, S. S. (2024). Epstein Barr virus‐directed T‐cell therapy for refractory EBV‐PTLD in a toddler post Orthotopic heart transplantation. Pediatric Transplantation. https://doi.org/10.1111/petr.14707
Vancouver
Work E, Gupta D, Slayton WB, Rees J, Coppola JA, Seifert R, et al. Epstein Barr virus‐directed T‐cell therapy for refractory EBV‐PTLD in a toddler post Orthotopic heart transplantation. Pediatric Transplantation. 2024. doi:10.1111/petr.14707
BibTeX
@article{Work2024,
author = {Work, Emily and Gupta, Dipankar and Slayton, William B and Rees, John and Coppola, John-Anthony and Seifert, Robert and Bleiweis, Mark S and Jacobs, Jeffrey P and Peek, Giles and Philip, Joseph and Brock, Alan and Rivera, Jose Hernandez and Sullivan, Kevin and Narasimhulu, Sukumar Suguna},
title = {Epstein Barr virus‐directed T‐cell therapy for refractory EBV‐PTLD in a toddler post Orthotopic heart transplantation},
journal = {Pediatric Transplantation},
year = {2024},
doi = {10.1111/petr.14707}
}
EUVIMED